Skip to content
DataLookout
Menu

Fudan University clinical trial pipeline

Get alerts when Fudan University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

18 trials changed in the last 30 days: 0 stopped, 7 with notable changes, 11 with minor changes only.

  1. Notable: CASTLE-ZS-04 · Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib · Advanced Biliary Tract Cancer Recruitment opened Fudan UniversityPhase 2 NCT07829874
  2. Minor: 6 trials marked Unknown by the registry's verification sweep Changed Registry verification sweep6 trials
    1. Minor: Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Fudan UniversityPhase 3 NCT04516681
    2. Minor: Lvosidenib (AK112) Combined With CapeOX and Radiotherapy · Unresectable Metastatic MSS-type Colorectal Cancer Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting Fudan UniversityPhase 2 NCT06593548
    3. Minor: Vaccine Chatbot for Improving Influenza Vaccination Uptake Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Fudan UniversityNot applicable NCT06657573
    4. Minor: AiRE-MS · AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Fudan UniversityNot applicable NCT06642948
    5. Minor: Multimodal Thermal Therapy · Early-stage Invasive Breast Cancer Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Fudan UniversityNot applicable NCT06635096
    6. Minor: Rechallenge of ADCs in MBC Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting Fudan UniversityNot specified NCT05571618
  3. Notable: BALISTA · BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC Primary completion pushed from Jan 31, 2026 to Dec 31, 2026 Fudan UniversityPhase 2 NCT06793332
  4. Notable: BCTOP-T-N01 · Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy · Triple Negative Breast Cancer Primary completion date changed from estimate of Aug 30, 2025 to May 30, 2026 Fudan UniversityPhase 3 NCT05999149
  5. Notable: EXPLORE · ReaL World Study of DS-8201 Primary completion date changed from estimate of Jun 30, 2025 to Apr 1, 2026 Fudan UniversityNot specified NCT06945224
  6. Notable: SPECTACLE · Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer Recruitment opened Fudan UniversityPhase 2 NCT07581795
  7. Notable: PROTECT · Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae Recruitment opened Fudan UniversityPhase 2 NCT07647029
  8. Minor: Real World Study of Sacituzumab Govitecan Primary completion pushed from Aug 1, 2026 to Dec 1, 2026 Fudan UniversityNot specified NCT06966141
  9. Notable: Family Physician Nudges for Influenza Vaccination Among Older Adults Enrollment reduced: 5250 → 3060 participants Fudan UniversityNot applicable NCT07864597
  10. Minor: INOVATE · Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases Primary completion pushed from Aug 30, 2026 to Jan 30, 2027 Fudan UniversityPhase 1/2 NCT07134153
  11. Minor: Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young · Early Endometrial Cancer Enrollment closed, study ongoing Fudan UniversityPhase 2 NCT05247268
  12. Minor: Renaissance · Reverse Triple Negative Immune Resistant Breast Cancer Enrollment increased: 80 → 90 participants Fudan UniversityPhase 2 NCT05076682
  13. Minor: G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation Trial sites expanded: 3 → 7 locations Fudan UniversityPhase 2 NCT07362810
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-18 NCT07945353 Orelabrutinib Plus 4 Gy Radiotherapy Versus 24 Gy Radiotherapy for Stage I/II MALT… Phase 2 Not Yet Recruiting
2026-11-16 NCT07939009 Knife Movement Rate Training for Endoscopic Submucosal Dissection: A Randomized Study Not Yet Recruiting
2026-11-13 NCT07934745 Radiotherapy Plus Putelimab and Vibostolimab for Advanced Anal Squamous Cell Carcinoma Phase 2 Not Yet Recruiting
2026-11-12 NCT07933679 SCRT Combined With CAPOX and PD-1 Antibody Versus LCRT Combined With CAPOX for Early… Phase 3 Not Yet Recruiting
2026-11-10 NCT07928427 Comparing Ultrafractionated and Moderate Hypofractionated Radiotherapy for Post-Surgery… Phase 3 Active, Not Recruiting
2026-11-06 NCT07920731 A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for… Phase 2 Enrolling by Invitation
2026-11-06 NCT07923812 Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A… Recruiting
2026-11-05 NCT07918079 Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC Therapy Phase 2 Not Yet Recruiting
2026-11-04 NCT07917104 Circulating Tumor DNA Methylation-Guided Adjuvant Therapy Decision-Making in Patients… Phase 2 Recruiting
2026-11-03 NCT07912710 China HEalthy Aging and Dementia Study (HEAD) Recruiting

Active trials by phase

Early Phase 1
4
Phase 1
4
Phase 1/2
18
Phase 2
257
Phase 2/3
7
Phase 3
78
Phase 4
14
Not charted: 189 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 35

Get alerts when Fudan University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free